HRH-10 Inhalation Mouthpiece Adapter for Pharmaceutical Aerodynamic Particle Size Distribution Testing
| Brand | Huironghe |
|---|---|
| Origin | Beijing, China |
| Manufacturer Type | Authorized Distributor |
| Country of Origin | China |
| Model | HRH-10 |
| Pricing | Available Upon Request |
| Material | Medical-Grade Silicone |
| Customization | Fully Configurable to ISO/USP/Ph. Eur.-Compliant Inhaler Interfaces |
| Compliance | Designed in Accordance with Chinese Pharmacopoeia (2020 Edition), USP <601>, and ISO 27427 |
Overview
The HRH-10 Inhalation Mouthpiece Adapter is a precision-engineered interface component designed exclusively for physicochemical characterization of pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), and soft-mist inhalers (SMIs) in regulated pharmaceutical development and quality control laboratories. It functions as a critical mechanical coupling between the patient-facing mouthpiece of an inhaler device and standardized aerodynamic assessment instrumentation—most commonly cascade impactors (e.g., Andersen Cascade Impactor, Next Generation Impactor) or inertial impaction-based systems. Its primary engineering objective is to maintain leak-tight pneumatic integrity throughout the entire actuation cycle, thereby preserving the fidelity of fine particle fraction (FPF), mass median aerodynamic diameter (MMAD), and geometric standard deviation (GSD) measurements. Unlike generic adapters, the HRH-10 is not a one-size-fits-all accessory; it is purpose-built to replicate the anatomical and dimensional constraints defined by pharmacopoeial test protocols—including those specified in the Chinese Pharmacopoeia (ChP) 2020 Edition, USP Aerosols, Nasal Sprays, and Metered Dose Inhalers, and ISO 27427:2013 Inhalation and Nasal Drug Products — Testing of Orally Inhaled and Nasal Drug Products. This ensures that airflow dynamics, velocity profiles, and particle deposition behavior observed during testing accurately reflect in vivo delivery conditions.
Key Features
- Medical-grade silicone construction certified to USP Class VI and ISO 10993-5 biocompatibility standards, ensuring chemical inertness and resistance to repeated sterilization cycles (autoclave, ethylene oxide, gamma).
- Zero-leak sealing architecture validated via helium leak testing (<1 × 10⁻⁶ mbar·L/s) under simulated inspiratory flow rates (28.3–90 L/min), meeting ICH Q5C stability protocol requirements.
- Modular interface design compatible with standard 22 mm conical connections (ISO 5356-1), while accommodating non-standard geometries—including tapered, flanged, and recessed mouthpieces—through bespoke tooling.
- Traceable dimensional metrology: each custom adapter undergoes CMM (coordinate measuring machine) verification against customer-supplied CAD models or physical reference samples, with full calibration certificate documentation.
- Integrated alignment guides and tactile feedback features to minimize operator-induced variability during assembly—critical for GLP-compliant dose uniformity testing per USP and ChP 0901.
Sample Compatibility & Compliance
The HRH-10 supports seamless integration with all major inhaler platforms, including but not limited to GlaxoSmithKline’s Diskus®, AstraZeneca’s Turbuhaler®, Teva’s ProAir RespiClick®, and proprietary generic pMDI actuators. Each configuration is validated for compliance with pharmacopoeial airway simulators (e.g., USP Apparatus 7, ChP Appendix XIX N) and meets the mechanical interface specifications outlined in ISO 27427 Annex B. All adapters are supplied with a Declaration of Conformity referencing ISO 13485:2016 Quality Management Systems for Medical Devices and are suitable for use in FDA-inspected facilities operating under 21 CFR Part 11–compliant data governance frameworks.
Software & Data Management
While the HRH-10 is a passive mechanical component, its use is fully traceable within validated laboratory information management systems (LIMS) and electronic lab notebooks (ELN). Batch-specific serial numbers are laser-engraved and cross-referenced in the Certificate of Conformance (CoC), enabling full audit trail linkage to instrument calibration records, impactor performance qualification (PQ) reports, and final analytical datasets. For customers implementing automated cascade impactor workflows (e.g., with Copley CI-2000 or MSP Next Generation Impactor controllers), Huironghe provides metadata templates compatible with ASTM E2865–22 data exchange standards.
Applications
- Aerodynamic particle size distribution (APSD) analysis per USP , ChP 0901, and Ph. Eur. 2.9.18.
- Delivered dose uniformity (DDU) and content uniformity (CU) testing in accordance with ICH Q5C and regulatory submission guidelines.
- Comparative in vitro bioequivalence (IVBE) studies supporting ANDA filings and generic inhaler approvals.
- Stability-indicating method development for accelerated and long-term storage condition assessments.
- Root cause investigation of formulation–device interaction failures during Stage 3 clinical manufacturing.
FAQ
Does the HRH-10 require recalibration when switching between different inhaler types?
No—each HRH-10 unit is calibrated and certified for its specific inhaler interface geometry at time of manufacture. Recertification is only required after physical damage or exposure to >121°C steam sterilization exceeding three cycles.
Can Huironghe support regulatory submissions with validation documentation?
Yes—custom adapters include IQ/OQ protocols, dimensional validation reports, leak test certificates, and material traceability dossiers aligned with FDA and NMPA expectations for ancillary test equipment.
Is the HRH-10 compatible with Next Generation Impactor (NGI) induction ports?
Yes—the standard configuration includes ISO 5356-1 compliant 22 mm male/female couplings and optional NGI-specific port inserts with pressure-drop-matched internal venturi profiles.
What lead time should be expected for custom adapter development?
Standard turnaround is 10–12 business days from receipt of finalized CAD drawings or physical sample; expedited prototyping (5-day delivery) is available with prior approval.

